The ADI-12 was developed to assess depressive symptoms among patients with amyotrophic lateral sclerosis (ALS) by excluding items which may detect somatic or motor impairment occurring secondary to motor neuron degeneration and not depression.
The ADI-12 was developed to assess depressive symptoms among patients with amyotrophic lateral sclerosis (ALS) by excluding items which may detect somatic or motor impairment occurring secondary to motor neuron degeneration and not depression.